Tower Research Capital LLC (Trc) Lyra Therapeutics, Inc. Put Options Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LYRA
# of Institutions
8Shares Held
3.09MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.83MShares$19.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY65.6KShares$442,9280.0% of portfolio
-
Jpmorgan Chase & CO New York, NY56.3KShares$379,8690.0% of portfolio
-
Diversified, LLC11.9KShares$80,5410.0% of portfolio
-
Ifp Advisors, Inc300Shares$2,0250.0% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $215M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...